Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Stock
Stocks
600196
CNE000000X38
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Shanghai S.E.
2026-10-16
|
5-day change | 1st Jan Change | ||
| 22.98 CNY | -0.91% |
|
-3.81% | -13.25% |
| 09-23 | Shanghai Fosun Unit Gets Global License for Two TCE Cancer Products | MT |
| 09-14 | Chinese Drug Regulator Accepts Fosun Pharma's Application for HLX14; Shares Up 5% | MT |
| Market Cap | 56.12B 8.39B 7.45B 6.91B 6.29B 11.86B 796B 12.05B 83.06B 32.56B 415B 31.48B 30.81B 1,324B | P/E 2026 * |
15.9x | P/E 2027 * | 13.8x |
|---|---|---|---|---|---|
| Enterprise Value | 68.98B 10.31B 9.16B 8.49B 7.73B 14.58B 978B 14.82B 102B 40.03B 511B 38.69B 37.87B 1,628B | EV / Sales 2026 * |
1.62x | EV / Sales 2027 * | 1.6x |
| Free-Float |
62.66% | Yield 2026 * |
1.96% | Yield 2027 * | 2.23% |
| 1 day | -0.91% | ||
| 1 week | -3.81% | ||
| Current month | -4.33% | ||
| 1 month | +5.51% | ||
| 3 months | -1.79% | ||
| 6 months | -12.12% | ||
| Current year | -13.25% |
| 1 week | 22.68 |  | 24.1 |
| 1 month | 22.12 | | 24.24 |
| Current year | 20.85 | | 28.71 |
| 1 year | 20.85 | | 29.68 |
| 3 years | 20.38 | | 33.1 |
| 5 years | 20.38 | | 58.95 |
| 10 years | 20.38 | | 91.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yi Liu
CEO | Chief Executive Officer | 50 | 2025-06-23 |
Zhi Huang
DFI | Director of Finance/CFO | - | 2026-04-01 |
Jing Li
PSD | President | 53 | 2023-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Qi Yu Chen
CHM | Chairman | 54 | 1994-03-31 |
Yi Liu
BRD | Director/Board Member | 50 | 2025-12-01 |
Dong Hui Pan
BRD | Director/Board Member | 56 | 2020-06-29 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/30/25 | Sell | Chief Executive Officer | 87,448 | 0.0041% | ||
| 5/30/25 | Sell | Executive/Senior Manager | 31,790 | 0.0015% | ||
| 5/30/25 | Sell | Chairman | 63,614 | 0.0030% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.91% | -3.81% | -19.99% | -19.79% | 8.39B | |
| +0.43% | +6.59% | +56.57% | +106.64% | 1,120B | |
| +0.90% | -2.25% | +32.26% | +63.73% | 616B | |
| +0.71% | +3.24% | +24.33% | +91.33% | 504B | |
| -0.13% | +5.98% | +33.66% | +50.18% | 367B | |
| +0.52% | +0.24% | +72.13% | +40.11% | 360B | |
| -0.95% | +4.70% | +19.65% | +42.71% | 288B | |
| -1.98% | +3.73% | -0.89% | +10.43% | 258B | |
| -0.35% | +4.25% | +44.74% | +52.06% | 234B | |
| -0.75% | +3.32% | +27.18% | +94.07% | 194B | |
| Average | -0.25% | +2.97% | +28.97% | +53.15% | 394.93B | |
| Weighted average by Cap. | +0.13% | +3.82% | +39.21% | +71.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 42.53B 6.36B 5.65B 5.24B 4.76B 8.99B 603B 9.13B 62.94B 24.68B 315B 23.85B 23.34B 1,003B | 43.6B 6.52B 5.79B 5.37B 4.88B 9.22B 618B 9.37B 64.53B 25.3B 323B 24.46B 23.94B 1,029B |
| Net income | 3.85B 576M 512M 475M 432M 815M 54.67B 828M 5.7B 2.24B 28.53B 2.16B 2.12B 90.95B | 4.3B 643M 571M 529M 482M 909M 60.99B 924M 6.36B 2.5B 31.83B 2.41B 2.36B 101B |
| Net Debt | 12.86B 1.92B 1.71B 1.58B 1.44B 2.72B 182B 2.76B 19.04B 7.46B 95.21B 7.21B 7.06B 304B | 14.06B 2.1B 1.87B 1.73B 1.58B 2.97B 199B 3.02B 20.82B 8.16B 104B 7.89B 7.72B 332B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-16 | CN¥22.98 | -0.91% | 19,298,364 |
| 26-10-15 | CN¥23.19 | -0.34% | 16,965,789 |
| 26-10-14 | CN¥23.27 | -1.02% | 13,536,766 |
| 26-10-13 | CN¥23.51 | -0.63% | 18,608,608 |
| 26-10-12 | CN¥23.66 | -0.96% | 17,793,400 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600196 Stock
Select your edition
All financial news and data tailored to specific country editions
